Certified by Founder Lodge
GeneCentric Therapeutics, Inc.
United States - Research Triangle Park, NC
START UP
1 Disclosed Funding Rounds $7,500,000
0 Participating Investments
-
Founded date
2011
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
GeneCentric was founded based on intellectual property from Drs. Neil Hayes and Chuck Perou’s laboratories at the Lineberger Comprehensive Cancer Center at the UNC School of Medicine.
Gene
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 08 ,2021 | Series B | $7,500,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Slate Medicines | $130,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
